

Platinum sponsor
Supported by Gilead Sciences Europe Ltd who provided funding. Gilead Sciences Europe Ltd. has had no input into the content of the materials and presentations used at this event..
Gilead Sciences has pursued – and achieved – breakthroughs once thought impossible in medicine for more than three decades, with the goal of creating a healthier world for all people.
At Gilead, we have pioneered more than 25 medicines since our founding in 1987 and have an expanding portfolio of investigational compounds.
We have helped transform care for people living with HIV, developing the world’s
first HIV single tablet regimen to treat the disease and the first medicines to prevent infection with the HIV virus. Our scientists are continuing to pursue new kinds of treatment, such as long-acting antivirals, and the ultimate goal: a cure.
Building on our success in HIV, we applied the same tenacity to hepatitis C virus (HCV), delivering four curative treatments in less than four years. Today, more than 4 million people have been prescribed our HCV therapies.
Through our Kite operating company in Southern California, we are on a path to a potential cure for cancer with our cutting-edge cell therapy program.
Through research and development we’re creating possibilities that include a wide range of clinical studies evaluating compounds with the potential to become the next generation of life-changing medicines. We believe the impossible is not impossible. It simply hasn’t been achieved yet.
N. | Title | Action |
---|---|---|
1 | Document Sample | |
2 | Document Sample | |
3 | Document Sample | |
4 | Video Sample | |
5 | Video Sample | |
6 | Video Sample |
Session Number | Presenter | Session | Presentation title | Access |
---|---|---|---|---|
S1-1 | Prof. Th. Dagklis | Session 1 - The contexts | The epidemiology of late parenthood | View Session |
S1-2 | Dr. A. Kaprara | Session 1 - The contexts | Pathophysiology of infertility in advanced age males | View Session |
S1-3 | Prof. N.P. Polyzos | Session 1 - The contexts | Pathophysiology of infertility in advanced age females | View Session |
S1-4 | Prof. L. Athanasiadis | Session 1 - The contexts | Psychological aspects of late parenthood | soon available |
S2-1 | Prof. N. Garrido Puchalt | Session 2 - The consequences | Pregnancy complications due to advanced paternal age | View Session |
S2-2 | Prof. Κ. Bambang | Session 2 - The consequences | Pregnancy complications due to advanced maternal age | View Session |
S2-3 | Prof. A. Pinborg | Session 2 - The consequences | Late parenthood: Short-term health of the offspring | View Session |
S2-4 | Prof. S.T. Davidge | Session 2 - The consequences | Pregnancy complications and long term health of the offspring | View Session |
S3-1 | Prof. H. Tournaye | Session 3 - The treatments | Management of infertility in advanced age males | View Session |
S3-2 | Prof. G. Griesinger | Session 3 - The treatments | Management of infertility in advanced age females | View Session |
S4-1 | Dr. Ch. Tsametis | Session 4 - The cases | Advanced paternal age | View Session |
S4-2 | Dr. J. Bosdou | Session 4 - The cases | Advanced maternal age | View Session |
S4-3 | Dr. V. Korvesi | Session 4 - The cases | Pregnancy complications | View Session |
S4-4 | Prof. G. Mitsiakos | Session 4 - The cases | Late parenthood: Offspring health, the case | View Session |
CC | Prof. D.G. Goulis, Prof. E.M. Kolibianakis | Conclusions and Closing | Conclusions and Closing | View Session |
ES-1 | Panelistas Sesión 1 - Coordinador: Juan Enrique Blümel | Sesión 1 - Impacto del Climaterio en la salud de la Mujer | Debate en climaterio - grabación en vivo, junio 19 | View Session |
ES-2 | Panelistas Sesión 2 - Coordinador: Antonio Cano | Sesión 2 - El arte del uso de hormonas en el climaterio | Debate en climaterio - grabación en vivo, junio 19 | View Session |
[contact-form-7 id=”2462″ title=”Comments to author”]
Physician and medical doctor from the University of Cadiz. Medical oncologist at the Clinical University Hospital of Valencia and Biomedical Research institute INCLIVA
Associate Professor of Medicine School at University of Valencia
She develops her assistance and research work in the breast pathology unit. She has an extensive experience in clinical trials and research projects in the area of breast cancer.Member of the breast cancer research group at the Carlos III institute.Member of the board of GEICAM (Spanish Breast Cancer Research Group)
Dr. Enrique Santas, MD, PhD, is a cardiologist at the Hospital Clínico Universitario in Valencia (Spain). He is an active clinician and an emergent researcher, with a focus on heart failure and cardiac imaging. Currently, he is the director of the cardio-oncology program at his institution, dedicated to the cardiovascular health of patients undergoing cancer treatment as well as cancer survivors.
If a HCP has a request for medical information regarding our Gilead products, they can contact us:
Via phone: +1-866-MEDI-GSI (1-866-633-4474), or
Submit an inquiry online at https://www.askgileadmedical.com/, via the webform under “Inquire”